glp-1 safety The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review Are GLP-1 Weight Loss Injections

Cell Mol Life Sci CMLS

Conclusion The development of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and their evolution into dual and triple receptor agonists represent an important advancement in the pharmacologic management of obesity

GLP-1 reduces intracellular ROS, prevents oxidative stress injury, and increases cellular protection in arterial endothelial and smooth muscle cells [70, 71]

Glutathione's skin-brightening mechanism works by temporarily and reversibly inhibiting tyrosinase, the enzyme central to melanin production this is a controlled, dose-dependent reduction in pigment production, not the destruction of melanin-producing cells that characterizes vitiligo, which is an autoimmune condition